# Vertex Pharmaceuticals net income entity: /record/vertex-pharmaceuticals.md predicate: net_income page: /record/vertex-pharmaceuticals/net_income as_of: 2026-11-10 cite: AsOf. "Vertex Pharmaceuticals quarterly net income: 653,600,000 United States dollar", as of 2026-09-30. Claim clm_466B90DBA1DE, https://asof.is/claim/clm_466B90DBA1DE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532026000291/0000875320-26-000291-index.htm. As of November 10, 2026, the latest net income figure on the AsOf record for Vertex Pharmaceuticals is $653.6 million for the quarter ended September 30, 2026, from a primary source (sec.gov). Vertex Pharmaceuticals's latest full-year net income is $3.95 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 17 claims on Vertex Pharmaceuticals's net income, 1 open and 16 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest net income The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_net_income claim, kept apart from the full-year series. - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_net_income | 653,600,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_466B90DBA1DE](/claim/clm_466B90DBA1DE.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532026000291/0000875320-26-000291-index.htm ## Latest full-year net income What the record asserts on 2026-11-10. - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | 3,953,200,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_406C31565DD9](/claim/clm_406C31565DD9.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | -642,178,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_6694DF685051](/claim/clm_6694DF685051.md) | [clm_25D63D0ED4EF](/claim/clm_25D63D0ED4EF.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000104746912001298/0001047469-12-001298-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | -754,626,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_D6D7CB158831](/claim/clm_D6D7CB158831.md) | [clm_6694DF685051](/claim/clm_6694DF685051.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000104746912001298/0001047469-12-001298-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | 29,574,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_117D40256E77](/claim/clm_117D40256E77.md) | [clm_D6D7CB158831](/claim/clm_D6D7CB158831.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000104746912001298/0001047469-12-001298-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | -107,032,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_59D5E0CC1F00](/claim/clm_59D5E0CC1F00.md) | [clm_117D40256E77](/claim/clm_117D40256E77.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532013000009/0000875320-13-000009-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | -445,028,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_E0C813E29FDB](/claim/clm_E0C813E29FDB.md) | [clm_59D5E0CC1F00](/claim/clm_59D5E0CC1F00.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532014000015/0000875320-14-000015-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | -738,555,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_3CC906E153DA](/claim/clm_3CC906E153DA.md) | [clm_E0C813E29FDB](/claim/clm_E0C813E29FDB.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532015000012/0000875320-15-000012-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | -556,334,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_2BC71558F3C9](/claim/clm_2BC71558F3C9.md) | [clm_3CC906E153DA](/claim/clm_3CC906E153DA.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532016000067/0000875320-16-000067-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | -112,052,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_EAA313C25D3D](/claim/clm_EAA313C25D3D.md) | [clm_2BC71558F3C9](/claim/clm_2BC71558F3C9.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532017000017/0000875320-17-000017-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | 263,484,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_D3A2B88BD1F9](/claim/clm_D3A2B88BD1F9.md) | [clm_EAA313C25D3D](/claim/clm_EAA313C25D3D.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532018000009/0000875320-18-000009-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | 2,096,896,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_FE5B5CF4FB84](/claim/clm_FE5B5CF4FB84.md) | [clm_D3A2B88BD1F9](/claim/clm_D3A2B88BD1F9.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532019000006/0000875320-19-000006-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | 1,176,810,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_79102BFD0743](/claim/clm_79102BFD0743.md) | [clm_FE5B5CF4FB84](/claim/clm_FE5B5CF4FB84.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532020000007/0000875320-20-000007-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | 2,711,647,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_F3A2B9FC81F1](/claim/clm_F3A2B9FC81F1.md) | [clm_79102BFD0743](/claim/clm_79102BFD0743.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532021000006/0000875320-21-000006-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | 2,342,100,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_1B7C3640D846](/claim/clm_1B7C3640D846.md) | [clm_F3A2B9FC81F1](/claim/clm_F3A2B9FC81F1.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532022000007/0000875320-22-000007-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | 3,322,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_DD75AE2A6FF1](/claim/clm_DD75AE2A6FF1.md) | [clm_1B7C3640D846](/claim/clm_1B7C3640D846.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532023000007/0000875320-23-000007-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | 3,619,600,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_B3A7B0C585DF](/claim/clm_B3A7B0C585DF.md) | [clm_DD75AE2A6FF1](/claim/clm_DD75AE2A6FF1.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532024000062/0000875320-24-000062-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | -535,600,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_406C31565DD9](/claim/clm_406C31565DD9.md) | [clm_B3A7B0C585DF](/claim/clm_B3A7B0C585DF.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532025000053/0000875320-25-000053-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | net_income | 3,953,200,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_406C31565DD9](/claim/clm_406C31565DD9.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm ## What replaced what - -$642.18 million (2009-12-31 to 2010-12-31, [clm_25D63D0ED4EF](/claim/clm_25D63D0ED4EF.md)) was replaced by -$754.63 million from 2010-12-31 ([clm_6694DF685051](/claim/clm_6694DF685051.md)) - -$754.63 million (2010-12-31 to 2011-12-31, [clm_6694DF685051](/claim/clm_6694DF685051.md)) was replaced by $29.57 million from 2011-12-31 ([clm_D6D7CB158831](/claim/clm_D6D7CB158831.md)) - $29.57 million (2011-12-31 to 2012-12-31, [clm_D6D7CB158831](/claim/clm_D6D7CB158831.md)) was replaced by -$107.03 million from 2012-12-31 ([clm_117D40256E77](/claim/clm_117D40256E77.md)) - -$107.03 million (2012-12-31 to 2013-12-31, [clm_117D40256E77](/claim/clm_117D40256E77.md)) was replaced by -$445.03 million from 2013-12-31 ([clm_59D5E0CC1F00](/claim/clm_59D5E0CC1F00.md)) - -$445.03 million (2013-12-31 to 2014-12-31, [clm_59D5E0CC1F00](/claim/clm_59D5E0CC1F00.md)) was replaced by -$738.56 million from 2014-12-31 ([clm_E0C813E29FDB](/claim/clm_E0C813E29FDB.md)) - -$738.56 million (2014-12-31 to 2015-12-31, [clm_E0C813E29FDB](/claim/clm_E0C813E29FDB.md)) was replaced by -$556.33 million from 2015-12-31 ([clm_3CC906E153DA](/claim/clm_3CC906E153DA.md)) - -$556.33 million (2015-12-31 to 2016-12-31, [clm_3CC906E153DA](/claim/clm_3CC906E153DA.md)) was replaced by -$112.05 million from 2016-12-31 ([clm_2BC71558F3C9](/claim/clm_2BC71558F3C9.md)) - -$112.05 million (2016-12-31 to 2017-12-31, [clm_2BC71558F3C9](/claim/clm_2BC71558F3C9.md)) was replaced by $263.48 million from 2017-12-31 ([clm_EAA313C25D3D](/claim/clm_EAA313C25D3D.md)) - $263.48 million (2017-12-31 to 2018-12-31, [clm_EAA313C25D3D](/claim/clm_EAA313C25D3D.md)) was replaced by $2.1 billion from 2018-12-31 ([clm_D3A2B88BD1F9](/claim/clm_D3A2B88BD1F9.md)) - $2.1 billion (2018-12-31 to 2019-12-31, [clm_D3A2B88BD1F9](/claim/clm_D3A2B88BD1F9.md)) was replaced by $1.18 billion from 2019-12-31 ([clm_FE5B5CF4FB84](/claim/clm_FE5B5CF4FB84.md)) - $1.18 billion (2019-12-31 to 2020-12-31, [clm_FE5B5CF4FB84](/claim/clm_FE5B5CF4FB84.md)) was replaced by $2.71 billion from 2020-12-31 ([clm_79102BFD0743](/claim/clm_79102BFD0743.md)) - $2.71 billion (2020-12-31 to 2021-12-31, [clm_79102BFD0743](/claim/clm_79102BFD0743.md)) was replaced by $2.34 billion from 2021-12-31 ([clm_F3A2B9FC81F1](/claim/clm_F3A2B9FC81F1.md)) - $2.34 billion (2021-12-31 to 2022-12-31, [clm_F3A2B9FC81F1](/claim/clm_F3A2B9FC81F1.md)) was replaced by $3.32 billion from 2022-12-31 ([clm_1B7C3640D846](/claim/clm_1B7C3640D846.md)) - $3.32 billion (2022-12-31 to 2023-12-31, [clm_1B7C3640D846](/claim/clm_1B7C3640D846.md)) was replaced by $3.62 billion from 2023-12-31 ([clm_DD75AE2A6FF1](/claim/clm_DD75AE2A6FF1.md)) - $3.62 billion (2023-12-31 to 2024-12-31, [clm_DD75AE2A6FF1](/claim/clm_DD75AE2A6FF1.md)) was replaced by -$535.6 million from 2024-12-31 ([clm_B3A7B0C585DF](/claim/clm_B3A7B0C585DF.md)) - -$535.6 million (2024-12-31 to 2025-12-31, [clm_B3A7B0C585DF](/claim/clm_B3A7B0C585DF.md)) was replaced by $3.95 billion from 2025-12-31 ([clm_406C31565DD9](/claim/clm_406C31565DD9.md)) ## Questions this record answers ### What is Vertex Pharmaceuticals's current net income? The latest figure on the record is $653.6 million for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $3.95 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 10, 2026. ### What was Vertex Pharmaceuticals's net income for the quarter ended September 30, 2026? $653.6 million for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did Vertex Pharmaceuticals's net income last change? The latest value on the record is $3.95 billion, dated December 31, 2025; before it the record holds -$535.6 million, dated December 31, 2024 and closed on December 31, 2025. ### What was Vertex Pharmaceuticals's net income before $3.95 billion? -$535.6 million, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/vertex-pharmaceuticals/net_income (markdown: /record/vertex-pharmaceuticals/net_income.md) - Entity twin: /record/vertex-pharmaceuticals.md ยท timeline: /timelines/vertex-pharmaceuticals.md - Every company's net income: /facts/net_income.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.